Similar articles

• Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States.

  Mvundura M, Amendah D, Kavanagh PL, Sprinz PG, Grosse SD. Mvundura M, et al. Pediatr Blood Cancer. 2009 Oct;53(4):642-6. doi: 10.1002/pbc.22069. Pediatr Blood Cancer. 2009. PMID: 19492318
• Cost of hospitalizations associated with sickle cell disease in the United States.

  Davis H, Moore RM Jr, Gergen PJ. Davis H, et al. Public Health Rep. 1997 Jan-Feb;112(1):40-3. Public Health Rep. 1997. PMID: 9018287 Free PMC article.
• Avoiding admission for afebrile pediatric sickle cell pain: pain management methods.

  Dumaplin CA. Dumaplin CA. J Pediatr Health Care. 2006 Mar-Apr;20(2):115-22; quiz 123-5. doi: 10.1016/j.pedhc.2005.12.016. J Pediatr Health Care. 2006. PMID: 16522488 Review. No abstract available.
• Sickle cell disease: a question of equity and quality.

  Smith LA, Oyeku SO, Homer C, Zuckerman B. Smith LA, et al. Pediatrics. 2006 May;117(5):1763-70. doi: 10.1542/peds.2005-1611. Pediatrics. 2006. PMID: 16651336
• Sickle cell disease--pathophysiology and treatment.

  Redding-Lallinger R, Knoll C. Redding-Lallinger R, et al. Curr Probl Pediatr Adolesc Health Care. 2006 Nov-Dec;36(10):346-76. doi: 10.1016/j.cppeds.2006.07.002. Curr Probl Pediatr Adolesc Health Care. 2006. PMID: 17055417 Review. No abstract available.